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Abstract
Background: Diabetes mellitus with the successive generation of reactive oxygen species signifies a major risk
factor for testicular dysfunction. Antioxidant supplements are one of the best options to prevent such disorder. In
the present study, lutein as dietary supplement has been used to explore its potential protective effects against
diabetes-induced oxidative stress in testicular cells.
Methods: Diabetes was induced using a single IP injection of streptozotocin (STZ). Lutein was mixed with rat chow
powder and supplemented to diabetic rats for 5 weeks. Serum testosterone levels were estimated. In testicular
cells, thiobarbituric acid reactive substances (TBARS), total sulfhydryl groups (T-GSH), non-protein sulfhydryl groups
(NP-SH), superoxide dismutase (SOD) and catalase (CAT) activities were measured. Pro-inflammatory mediators like
tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) were measured in the testis. Nucleic acids and total protein
(TP) levels were also estimated in testicular cells. Histopathological changes were evaluated in testis.
Results: Serum testosterone level was significantly decreased in diabetic animals compared to controls. Diabetes
markedly reduced T-GSH, NP-SH, CAT and SOD, while TBARS, TNF-α and IL-1β levels were increased in the diabetic
testis compared to non-diabetic controls. Lutein supplementation, significantly and dose dependently increased
the serum testosterone level. The elevated TBARS levels were significantly decreased compared to diabetic group,
while the decreased levels of T-GSH and NP-SH and activities of CAT and SOD were found increased by lutein
treatments in dose dependent manner. Lutein pretreatment also inhibited the TNF-α and IL-1β levels compared to
diabetic group. The decreased values of nucleic acids and total protein in diabetic group were also significantly
increased in lutein supplemented groups. The histopathological evaluation revealed protection the damaged testicular
cells in the diabetic rats by lutein supplementation.
Conclusion: These findings showed that lutein has potential beneficial effects in diabetes-induced testicular damage,
probably through its antioxidant and anti-inflammatory properties.
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Background
Male reproductive alterations have been widely reported in
experimental animal model and human with diabetes [1].
Streptozotocin (STZ) induced diabetes in male rats results
in atrophy of sex organ, changes in histoarchitecture of
ventral prostate [2], decrease in sperm count [3], along
with low levels in plasma testosterone [4]. Oxidative stress
is one of the major pathophysiological routes during dia-
betes mellitus (DM) [5, 6]. Persistent hyperglycemia leads
to the formation of advanced glycation end-products
(AGEs) which are the products of non-enzymatic reactions
between glucose and lipids, proteins or nucleic acids [7].
AGEs and glucose auto-oxidation might contribute to
diabetes-induced sexual dysfunction by generating oxygen
free radicals especially reactive oxygen species (ROS),
which induce oxidative cellular damage and quench nitric
oxide (NO), terminating in decreased cyclic guanosine
monophosphate (cGMP) and impairing cavernosal smooth
muscle relaxation [7]. Furthermore, ROS are positively cor-
related with both insulin resistance and the deterioration
of cell function in the context of concomitant hypergly-
cemia [6, 8] and their cytotoxic effects are usually accom-
panied with an increase in lipid peroxidation, alteration of
the glutathione redox state, a decrease in the content of
individual natural antioxidants, and decreased induction
of antioxidant enzymes [9]. Several studies reported
hyperglycemia-induced elevation of proinflammatory
cytokines in serum of diabetic individuals [10, 11]. This
elevation was abolished by supplementation of the anti-
oxidants suggesting that hyperglycemia-induced cytokine
production may be mediated by ROS [12].
Fruits and vegetables contain a vast array of antioxidant
components, which possess several physiological proper-
ties including, protection against oxidative stress-mediated
diseases. Lutein is one of those most widely distributed
carotenoids in fruits and vegetables having antioxidant
properties [13]. It is not naturally produced by the human
body; therefore, it must be obtained through the con-
sumption of foods containing large amount of lutein such
as dark-green leafy vegetables kale, spinach, turnip greens,
and collards [14]. A number of recent studies have
discussed the protective effects of lutein against different
eye diseases, mainly age-related macular degeneration,
correlating the reported to the antioxidant property of
lutein [15–17]. The mechanisms of antioxidant activity of
lutein is well established and extensively described in the
literature [16, 18].
Diabetes-induced sexual dysfunction is considered one
of the most prevalent diabetic complications where oxida-
tive stress and inflammation are deemed to play vital role
in its pathogenesis. It can be anticipated that lutein via its
reported antioxidant and anti-inflammatory properties
may protect the diabetes-induced testicular damage from
the deleterious effects of ROS and inflammation. Thus,
the study was designed to investigate the protective ability
of lutein on diabetic associated testicular dysfunction in
STZ animal model of DM.
Methods
Animals
Male Wistar albino rats (12 to 13 weeks old) weighting
260 ± 10 g were received from Experimental Animal
Care Center, College of Pharmacy, King Saud University,
Riyadh, Saudi Arabia. All animals were maintained
under controlled conditions of temperature (22 ± 1 °C),
humidity (50-55 %), light (12 h light/12 h dark cycle)
with free access to Purina rat chow (Manufactured by
Grain Silos & Flour Mills Organization, Riyadh, Saudi
Arabia) and drinking water. Animals were acclimatized
to the laboratory conditions for 7 days. All experimental
procedures including handling, treatment and euthanasia
were conducted in accordance with the National Institute
of Health Guide for the Care and Use of Laboratory
Animals (NIH Publications No. 80–23; 1996) as well as
the Ethical committee of Experimental Animal Care Cen-
ter, College of Pharmacy, King Saud University, Riyadh,
Saudi Arabia obtained approval (238-EACC-2014).
Diet
Experimental diets were prepared in pellet form by add-
ing lutein in three different doses 40 mg/kg, 80 mg/kg
and 160 mg/kg in rat chow powder following shade dry
method. The above doses are calculated on the bases of
food intake of diabetic rats as 35 to 40 g per day, thus
the range of our doses will be in between 1.5 to 6 mg/
day. Lutein was purchased from Carbone Scientific Co.,
Ltd (Product number C-23248, London, UK). During
whole experimental period, all groups of animals were
kept on free access to food and water.
Diabetes induction
Induction of experimental diabetes was done using sin-
gle intraperitoneal injection of STZ (Sigma) dissolved in
citrate buffer (pH 4.5) at the dose of 65 mg/kg to over-
night fasted rats. Control animals received intraperito-
neal injection of citrate buffer only as vehicle. Forty-
eight hours later, animals were fasted and blood glucose
levels were analyzed using a glucometer (ACCU-CHEK
ACTIVE, Roche, Germany). Animals with blood glucose
levels above 250 mg/dL were considered as diabetic.
Experimental design
Six normal healthy rats were taken in control group and
diabetic rats were randomly divided into four groups by
taking six in each, as follows;
(1) Non-Diabetic (ND)
(2) Diabetic (D)
Fatani et al. BMC Complementary and Alternative Medicine  (2015) 15:204 Page 2 of 10
(3) Diabetic supplemented with lutein (40 mg/kg diet)
(D + L40)
(4) Diabetic supplemented with lutein (80 mg/kg diet)
(D + L80)
(5) Diabetic supplemented with lutein (160 mg/kg diet)
(D + L160)
Lutein content diets were supplemented at free ac-
cess to diabetic rats for 5 weeks. The general health
of the animals was observed during treatment period
and their body weights were recorded at the begin-
ning of every week throughout the study period. At
the end of the 5th week, blood samples were collected
through the cardiac puncture under light anesthesia.
Animals were then sacrificed and their testicular tis-
sues were dissected and stored at −80 °C till analysis.
A small testicular cross section from each group was
fixed in 10 % formaldehyde solution for histopatho-
logical evaluation.
Estimations of glucose, insulin and testosterone levels in
serum
Serum levels of glucose were measured using the com-
mercially available kit (RANDOX Laboratories Ltd., UK)
while insulin and testosterone levels in serum were
assayed using ELISA kit (Cayman Ltd., USA) according
to the manufacturer’s instructions.
Estimations of TNF-α and IL-1β levels in testicular cells
Proinflammatory cytokines including TNF-α and IL-1β
levels in testicular cells were assessed and quantified
(pg/mg protein) by using ELISA technique (R & D
systems, USA).
Estimation of TBARS levels in testicular cells
Levels of thiobarbituric acid reactive substances (TBARS)
were estimated using biochemical assay kit (ZeptoMetrix)
by measuring the lipid peroxidation products, malon-
dialdehyde (MDA) equivalents. 0.1 mL of testis hom-
ogenate was mixed with 2.5 mL reaction buffer
(provided by the kit) and heated at 95 °C for 60 min.
After cooling, the absorbance of the supernatant was
measured at 532 nm. The quantified MDA levels were
expressed as nmole/mg protein.
Estimations of T-GSH and NP-SH levels in testicular cells
Total sulfhydryl group levels were estimated following
the method described by Sedlak and Lindsay [19].
Testis homogenate was mixed with 0.2 M Tris buffer
(pH 8.2), 0.01 M Ellman’s reagent and 5,5’-dithiobis-(2-
nitro-benzoic acid) (DTNB). After centrifugation at
room temperature, the absorbance of the clear super-
natants was measured at 412 nm. For non-sulfhydryl
group estimations, testis homogenate was mixed with
50 % trichloroacetic acid solution (TCA). Then after
shaking intermittently for l0-15 min, samples were
centrifuged for 15 min and 2 mL of the supernatant
was mixed with 4 mL of 0.4 M Tris buffer (pH 8.9) and
0.1 ml DTNB. The absorbance was read within 5 min
at 412 nm.
Assessment of enzymatic activities SOD and CAT in
testicular cells
Testicular SOD activity was estimated following the
method described by Kono, [20]. Superoxide anions
were generated by the oxidation of hydroxylamine
hydrochloride. The reduction of nitroblue tetrazolium
to blue formazan mediated by superoxide anions was
measured at 560 nm under aerobic conditions. Addition
of SOD inhibited the reduction of nitroblue tetrazolium
and the extent of inhibition was taken as a measure
of enzyme activity. Testicular CAT activity was esti-
mated following the method described by Aebi, [21].
Briefly, 0.5 mL of the post-mitochondrial supernatant
was mixed with 50 mM phosphate buffer (pH 7.0) and
20 mM H2O2. The estimation was done using spe-
ctrophotometer following the decrease in absorbance
at 240 nm.
Estimation of nucleic acids and total protein (TP) levels in
testicular cells
Nucleic acids in testicular cells were estimated following
the method described by Bregman, [22]. In brief, homog-
enates were suspended in 10 % ice-cold trichloroacetic
acid (TCA). Then after centrifugation, pellets were ex-
tracted with 95 % ethanol twice. Nucleic acids extract
was treated either with diphenylamine or orcinol reagent
for DNA and RNA quantification respectively. The modi-
fied Lowry method by Schacterle and Pollack, [23] was
used to estimate levels of TP in testis using bovine plasma
albumin as a standard.
Histopathological assessment of the testicular tissues
Testicular cross sections fixed in 10 % formaldehyde so-
lution then embedded into paraffin wax blocks and cut
using a microtome. Samples were stained with haema-
toxylin and eosin stain (H&E), mounted and observed
microscopically by a histopathologist in blinded fashion
to avoid any kind of bias.
Statistical analysis
Data were expressed as mean ± standard error of mean
(SEM) and statistically analyzed using one-way ANOVA
followed by Student-Newman-Keuls multiple compari-
sons test. Graph Pad prism program (version 5) was
used as analyzing software.
Fatani et al. BMC Complementary and Alternative Medicine  (2015) 15:204 Page 3 of 10
Results
Effects on fasting blood glucose, insulin levels and animals
body weights
Fasting glucose and insulin levels were significantly
increased and decreased in diabetic animals compared
to control rats respectively. These changes were not
markedly altered with the lutein dietary (40, 80 and
160 mg/kg diet) supplementations. Mean body weights
and testis weight compared to body weights (g/100 g
body weight) of diabetic rats found significantly de-
creased. The experimental diets could not alter the
body and testis weights in diabetic rats compared to
normal diet fed diabetic rats (Table 1).
Effects on serum testosterone levels
Serum levels of testosterone showed a significant de-
crease in diabetic animals compared to control rats. Five
weeks of lutein (80 and 160 mg/kg) diets supplementa-
tion revealed significant increase in decreased levels of
serum testosterone (Fig. 1).
Effects on testicular pro-inflammatory cytokines
Testicular levels of pro-inflammatory cytokines includ-
ing TNF-α and IL-1β were significantly increased in
diabetic rats compared to control animals. Lutein sup-
plementation with medium and higher doses (80 and
160 mg/kg) to diabetic rats for five weeks revealed in-
hibition in IL-1β while TNF-α levels decreased only in
160 mg/kg lutein diet supplemented group when com-
pared to normal diet fed diabetic rats (Fig. 2).
Effects on testicular lipid peroxidation and oxidative stress
In testicular tissues of diabetic animals, TBARS levels
found significantly increase as compared to control
group of rats. Lutein dietary supplementation to diabetic
rats with medium and higher doses revealed significant
inhibition in the elevated levels of TBARS as compared
to normal diet fed diabetic rats. In sulfhydryl groups,
both T-GSH and NP-SH levels markedly reduced in tes-
ticular cells of diabetic animals compared to healthy ani-
mals. Supplementations with the medium and high
doses of lutein content diets (80 and 160 mg/kg) to
diabetic rats significantly ameliorated the reduced levels
of testicular T-GSH and NPSH in diabetic rats (Fig. 3).
Testicular antioxidant enzymes (SOD and CAT) activ-
ities were decreased significantly in diabetic animals as
compared to control group of rats. Five consecutive
weeks of treatment with the medium and higher doses
of Lutein (80 and 160 mg/kg/day) significantly enhanced
the reduced activities of CAT as compared to diabetic
group (Fig. 4), while only the higher dose of lutein
(160 mg/kg/day) significantly inhibited the STZ-induced
decrease in SOD testicular activity (Fig. 4).
Effects on testicular nucleic acids and total proteins
There was a significant decrease in testicular DNA,
RNA and TP concentrations in the diabetic groups of
animals as compared to normal animals (Fig. 5). The re-
duced levels of testicular DNA were significantly attenu-
ated by both the medium and higher doses of lutein (80
and 160 mg/kg), while only the higher dose of lutein
(160 mg/kg/day) brought back RNA levels to its normal
Table 1 Effect of lutein on body and organ weight in of diabetic animals
Treatments Glucose (dl/L) Insulin (ng/ml) Body weight (g) Testis
weight g/100 gInitial Final
ND 130.83 ± 3.28 25.65 ± 3.51 215.33 ± 5.01 327.17 ± 13.08 0.10 ± 0.09
D 526.17 ± 27.81*a 11.65 ± 1.21*a 202.00 ± 4.96 190.33 ± 14.72*a 0.50 ± 0.12*a
D + L(40) 507.17 ± 16.11 12.56 ± 2.54 224.87 ± 6.57 198.00 ± 6.92 0.67 ± 0.15
D + L(80) 493.83 ± 23.36 13.24 ± 2.16 232.28 ± 3.69 189.5 ± 9.13 0.75 ± 0.16
D + L(160) 465.83 ± 28.17 13.68 ± 2.07 223.28 ± 6.10 179.67 ± 7.51 0.85 ± 0.07
Data were expressed as Mean ± SEM. and analyzed using one-way ANOVA followed by Student-Newman-Keuls multiple comparisons test (n = 6). Difference between
groups was considered statistically significant when (*) P ≤ 0.05. (a) D group was compared with ND group
Fig. 1 Effect of lutein on serum level of testosterone in diabetic
rats. Note the lutein dose dependent for monitoring the level of
testosterone up to ND group. Data were expressed as Mean ± SEM.
and analyzed using one-way ANOVA followed by Student-Newman-
Keuls multiple comparisons test (n = 6). Difference between groups
was considered statistically significant when (*)P≤ 0.05, (**)P≤ 0.01
and (***)P≤ 0.001. (a)D group was compared with ND group; (b)lutein
treated groups were compared with D group
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values (Fig. 5). The reduced levels of TP was significantly
increased in lutein supplemented groups as compared to
untreated diabetic rats (Fig. 5).
Effects on testicular histopathological features
Histopathological investigation of the ND group revealed
germinal epithelium forms about 90 % and Stromal
about 10-15 %. The germinal cells are complete up to
spermatids and full sperm maturation. The interstitial
tissue shows a full spermatogenesis (Fig. 6 a-1, A-2 and
A-3). In the D group, there was a marked thickening of
the basement membrane and abnormal configurations
with elongation of the tubules with variable in size and
contour. The spermatogonia cells show degeneration in
most of the tubules while they are proliferating in others.
Fig. 2 Effect of lutein on testicular levels of (a) IL-1β and (b) TNF-α
of diabetic rats. Note the down regulation of both cytokines on the
lutein dose- dependent groups was compared to D group. Data
were expressed as Mean ± SEM. and analyzed using one-way ANOVA
followed by Student-Newman-Keuls multiple comparisons test (n = 6).
Difference between groups was considered statistically significant
when (*) P ≤ 0.05 and (**) P ≤ 0.01. (a)D group was compared with
ND group; (b)lutein treated groups were compared with D group
Fig. 3 Effect of lutein on testicular levels of (a) TBARS, (b) T-GSH and
(c) NPSH of diabetic rats. Note a significant decreased of TBARS in
group treated lutein (160 mg) comparing to diabetic one, while highly
significant increased was noticed in the T-GSH and NPSH. Data
were expressed as Mean ± SEM. and analyzed using one-way
ANOVA followed by Student-Newman-Keuls multiple comparisons
test (n = 6). Difference between groups was considered statistically
significant when (*) P≤ 0.05 and (**) P≤ 0.01. (a) D group was compared
with ND group; (b) lutein treated groups were compared with D group
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Also, the maturation is up to primary spermatogonia
and the inter stitial tissue was edematous and contains
numerous thickened wall dilated and congested blood
vessels (Fig. 6 b-1, b-2 and b-3). Results of the D + L40
group demonstrated numerous semineferous tubules
that were variable in size and contour. Spermatogonia
cells are few with degeneration and the maturation was
up to primary spermatocyte. Sertoli cells are numerous
and some tubules had desquation and degeneration of
the spermatogonia cells. The interstial tissue was focally
edematous with congested vessels (Fig. 6 c-1, c-2 and
c-3). Histological results of D + L80 group showed
numerous semineferous tubules with thin basement
membrane. The abnormal configurations are few and
the tubules were slightly variable in size and contour.
They were lined by spermatogonia cells up to primary
Fig. 4 Effect of lutein on testicular activities of (a) SOD and (b) CAT
of diabetic rats. Note the up regulating of both enzymes on the lutein
dose dependent groups comparing to D group. Data were expressed
as Mean ± SEM. and analyzed using one-way ANOVA followed by
Student-Newman-Keuls multiple comparisons test (n= 6). Difference
between groups was considered statistically significant when (*) P≤ 0.05
and (**) P≤ 0.01. (a)D group was compared with ND group; (b)lutein
treated groups were compared with D group
Fig. 5 Effect of lutein on testicular levels of (a) DNA, (b) RNA and
(c) TP of diabetic rats. Note the lutein dose- dependent of monitoring
the expression of DNA, RNA and TP were increased up to ND group.
Data were expressed as Mean ± SEM. and analyzed using one-way
ANOVA followed by Student-Newman-Keuls multiple comparisons
test (n = 6). Difference between groups was considered statistically
significant when (*) P≤ 0.05, (**) P≤ 0.01 and (***)P≤ 0.001. (a)D group
was compared with ND group; (b)lutein treated groups were compared
with D group
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Fig. 6 Histopathological sections of testis from rats stained with H&E (4, 10 and 40X; respectively). Testicular microscopic image of [a] Normal
rat testis from ND group; [b] Diabetic rat testis with degenerated and edematous spermatogonia cells with dilated and congested blood vessels;
[c, d & e] dose dependent reparative testicular changes and edematous healing lutein treated rats (40, 80 and 160 mg/kg, respectively)
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spermatogonia. Sertoli cells, spermatids and sperms were
present and the interstitial tissue shows no edema or
congestion (Fig. 6 d-1, d-2 and d-3). Testis from
animals fed with the high dose of lutein (160 mg/kg)
showed numerous semineferous tubules, with few scat-
tered abnormal convolutions. The spermatogonia in
most of the tubules are degenerated. Some tubules show
focal proliferations of the spermatogonia. The tubules
are slightly variable in size and contour and the intersti-
tial tissue shows no edema or congestion (Fig. 6 e-1, e-2
and e-3).
Statistical analysis
Data were expressed as Mean ± SEM. and analyzed using
one-way ANOVA followed by Student Newman-Keuls
multiple comparisons test (n = 6). Difference between
groups was considered statistically significant when (*)
P ≤ 0.05, (**) P ≤ 0.01 and (***) P ≤ 0.001. (a) D group was
compared with ND group; (b) lutein treated groups were
compared with D group.
Discussion
The present investigation outlines the protective effects
of lutein against experimentally induced diabetic sexual
oxidative dysfunction in Wistar rats. The preventative
properties of lutein were confirmed by the histological
evaluation. Administration of lutein for five consecutive
weeks markedly reduced signs of testicular inflam-
mation, lipid peroxidation, oxidative stress and cellular
damage induced by hyperglycemia.
STZ-induced diabetes in rodents appears to be the
most suitable animal model because it reflects the symp-
toms of diabetes in human [24] and it is characterized
by severe loss in body weight, and this is also reflected
in the present study. The decreases in body and testis
weight in diabetic rats showed the loss or degradation of
structural proteins due to diabetes and a significant
reduction in the serum levels of the main androgenic
hormone, testosterone [25]. Indeed, the role of oxidative
impairments in the male reproductive system has been
suggested in several experimental studies [26–28]. In-
duction of lipid peroxidation process and elevation of its
biomarker like TBARS in the testicular tissues was
shown to have fundamental implications on testicular
physiology and sperm function [29]. DM is well known
to be strongly correlated with oxidative stress leading
to production of free radicals and act as intercellular
second messengers that can induce activation down-
stream signaling of many molecules, including transcrip-
tion factors like nuclear factor kappa B (NF-κB). These
NF-κB and other transcription factors mediate vascular
smooth muscle cell growth and migration as well as the
expression of pro-inflammatory cytokines such as TNF-α,
IL-1β, and IL-6 [30]. The present results revealed
markedly elevation in the levels of TNF- α and IL-1 β in
the diabetic group of animals. These elevated pro-
inflammatory mediators antagonize insulin action because
of their ability to augment insulin receptor substrate
phosphorylation, leading to insulin resistance [31, 32].
Therefore, attenuation of free radical induced NF-κB
translocation and ameliorating oxidative stress in dia-
betic rats explains an associative relationship between
the inflammatory cytokines and DM. In the present
study, both endogenous antioxidants total and non pro-
tein sulfhydryl molecules were found to be inhibited in
the diabetic group. Moreover, activities of the antioxi-
dant enzymes SOD and CAT were markedly reduced in
the testis of the diabetic animals. The present data dem-
onstrated the significant elevation of lipid peroxidation
biomarker MDA in testicular tissues of diabetic animals.
These findings are consistent with the increased cellular
oxidative stress and accumulation of lipid peroxides
levels demonstrated in experimental type-I DM [33]. It is
well documented that the endogenous sulfhydryl mole-
cules have intracellular antioxidant properties and several
biological functions such as cellular protection against
oxidation via a strong nucleophilic action that protects
nucleic acids, proteins, and other bio-molecules from ROS
[34]. In this regard, a decreased level of T-GSH and
NP-SH implicates the reduction of the nucleic acids and
TP concentrations in testicular tissues of the diabetic ani-
mals reported in our study, which indicates cytotoxicity
and oxidative injury of male reproductive organs.
Abundantly antioxidants are present in natural re-
sources and they could have an important influence on
human health. Lutein is one of the most widely distrib-
uted carotenoids [35] and it is considered as the second
most prevalent carotenoid in human serum [36]. Lutein
is the only carotenoid that is absorbed in the blood
stream after ingestion [35] and accumulated in the
human tissue. It showed several biological beneficial
properties against different pathological conditions in-
cluding cell transformation, monocyte-mediated inflam-
matory response, oxidative stress, LDL oxidation and
macula injury [37–40] as well as amelioration of the
effects of degenerative human diseases, such as age-
related macular degeneration [41, 42] or cataract [43].
Several studies suggested that lutein may help maintain
heart health by reducing the risk of atherosclerosis [40, 44].
Lutein treated groups revealed inhibition in diabetes-
induced reduction of serum levels of testosterone. In
addition that, the histopathological results showed
lutein can protect the diabetic associated testicular
tubules alterations of their size and contour. Lutein also
protected spermatogonia cells from diabetes-induced
degeneration, immaturation and congestion.
The structures of lutein is characterized by the presence
of two hydroxyl groups, one on each side of the molecule,
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which are believed to play a critical role in its biologic
function [35, 45]. Thus, lutein can be considered as
effective quenchers of singlet oxygen and related reactive
oxygen species [17, 46]. In addition to quenching ROS
directly, lutein was reported to effectively prevent pro-
tein, lipid or DNA from oxidative damage by regulating
other cellular antioxidant systems [47]. However, in
present study, diabetes-induced inhibition in testicular
levels of sulfhydryl groups were found to be increased
by lutein content dietary supplementation in rats.
Similarly, inhibited antioxidant enzymes SOD and CAT
activities were also improved following lutein dietary
supplementations. Furthermore, the elevated levels of tes-
ticular lipid peroxidation product, MDA levels were also
markedly lowered by lutein supplementations in the dia-
betic rats. The cytoprotective effect of lutein was found in
the present study as revealed significant improvement in
the decreased levels of cellular nucleic acids and total pro-
teins in testicular cells of diabetic rats. It has shown that
lutein supplementation effectively blocked the H2O2-in-
duced protein oxidation, lipid peroxidation and DNA
damage in lens of epithelial cells. Moreover, lutein supple-
mentation considered the increase in the levels of GSH
and GSSG, particularly after H2O2 challenge [47]. This
finding revealed the ability of lutein for modulating lipid
peroxidation and ROS production, it may be suggested
through the protective effect of lutein.
Oxidative stress triggers inflammatory process via
vicious cycle [48, 49]. However, the regulation of ROS
might inhibit the tissue damage caused by inflammatory
reactions. In support of this idea, several reports using
animal models suggest that the administration of
antioxidants reduces ROS and is effective for preventing
or treating inflammatory diseases such as rheumatoid
arthritis [50], arteriosclerosis [51], vascular changes in
diabetes [52] and inflammatory bowel disease [53]. In
the present investigation, lutein showed an antiinflam-
matory effects as it significantly reduced the augmented
testicular levels of proinflammatory cytokines like TNF-
α and IL-1β. Earlier its antiinflammatory properties
have been demonstrated in mammalian systems [54].
Lutein modulated the inflammatory response is sug-
gested to be via protecting the proteasome from inacti-
vation by oxidative stress [55].
Conclusion
From the above discussion, it may be concluded that
lutein has a significant protective effect on testicular
dysfunctions noted in STZ induced diabetic state. The
actual mechanism for such protection is not clear from
this work. However, it may contribute to its antioxidative
and antiinflammatory properties. Further investigations
are still needed to confirm and evaluate these effects in
both experimental and clinical levels.
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